Bredis Healthcare Participates in the 18th Annual Conference of the Korean Society for Neurodegeneration

Hello, this is Bredis Healthcare!

Bredis Healthcare participated in the 18th Annual Conference of the Korean Society for Neurodegeneration (KSND 2026), held on September 5 at the Baekbeom Kim Koo Museum Convention Hall in Seoul.

The Korean Society for Neurodegeneration is one of Korea's leading academic organizations dedicated to advancing research and clinical practice in neurodegenerative diseases, including Parkinson's disease, Alzheimer's disease, and ALS (Amyotrophic Lateral Sclerosis). The annual conference serves as a premier gathering where experts in the field come together to share the latest research findings and clinical insights.

Bredis Healthcare operated an exhibition booth, introducing our biomarker analysis services utilizing SIMOA and NULISA, with a focus on neurology. To highlight p-tau217 — a key blood biomarker for the early prediction of Alzheimer's disease — we ran a fun and interactive challenge at our booth: visitors were invited to stop a stopwatch at exactly 2.17 seconds! ⏱️ More than just a game, the event was designed to help attendees naturally remember the significance of p-tau217 in Alzheimer's research. We were thrilled by the enthusiastic participation from so many attendees, which kept our booth lively and energetic throughout the day.

Bredis Healthcare will continue to stand alongside researchers and clinicians in the field of neurodegenerative diseases, delivering better products and services. Thank you for your continued support! 😊